Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class ASSE: 688266

Announcement on Attending the 2024 Semi-annual Collective Performance Briefing for Pharmaceutical and Biological Products Companies on STAR Market

· Issued by Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Attending the 2024 Semi-annual Collective Performance Briefing for Pharmaceutical and Biological Products Companies on STAR Market

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis